Skip to content

News & Updates

NovoNordisk announces positive results with oral semaglutide

By

Updated

NovoNordisk

Novonordisk the leading Danish company for producing anti diabetic drugs announces  positive results for phase II testing of the oral hypoglycemic semaglutide.

In the trails semaglutide appeared to be safe and well tolerated with nausea and vomiting diminished over time.

“We are very pleased with the results of this trial confirming the potential of semaglutide to treat type 2 diabetes, both as a once weekly subcutaneous injection and as a once daily tablet”
Said Mads Krogsgaard Thomsen
executive vice president and chief science
officer of Novo Nordisk
Full announcement HERE.
Share
News & Updates

Happy day for Sanofi new drug Toujeo®

Sanofi , France based company got FDA approval of its new drug Toujeo®.  Toujeo is once daily insulin based on widely used insulin glargine. February 27, 2015 , Sanofi announces a positive opinion from European Medicines Agency (EMA) recommending  approval of Toujeo injection for treatment of type 1 and type 2 diabetic patients. Toujeo showed…

Feb 27, 2015

General

Top 10 pharmaceutical products in 2023 with MoA – ranked!

This following list has the top 10 drugs that have the potential to be game-changers in the field of medicine and provide new hope for patients with serious diseases. They are ranked by the projected USD sales in billions. Drug Company Disease Projected sales (billion USD) Mechanism of action Keytruda Merck & Co. Cancer 24…

Aug 28, 2023

Drug facts

Insulin Comparison Chart

Insulin Name When does it start working? (onset) When will the effect be the greatest? (peak) How long will it lower blood glucose? (duration) Notes for Use Cost estimate Rapid Acting Lispro (HumalogTM) <15 minutes 0.5-3 hours* 3-5 hours If mixing with NPH, rapid acting insulin should be drawn into syringe first. Mixture should be…

Jul 16, 2017

Drug facts

Mode of Action for Antibiotic Classes – Quick tips

Knowing how do Antibiotics work and fight the infection is an important step for treatment. Resistance is emerging rapidly to most classes and we have to control the use of Antibiotics and avoid misuse or overuse in both community and healthcare society. Developing Antibiotics resistance has many unfavorable outcomes: Increase the rates of mortality and…

Apr 5, 2017